Total Payments
$10,519
2024 Payments
$1,678
Companies
50
Transactions
584
Medicare Patients
54,721
Medicare Billing
$2.8M
Payment Breakdown by Category
Food & Beverage$10,513 (99.9%)
Education$6.02 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,513 | 583 | 99.9% |
| Education | $6.02 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,133 | 93 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $815.90 | 83 | $0 (2021) |
| GlaxoSmithKline, LLC. | $710.64 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $651.45 | 32 | $0 (2024) |
| Novo Nordisk Inc | $624.49 | 39 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $602.93 | 36 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $452.06 | 22 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $407.22 | 9 | $0 (2024) |
| Amarin Pharma Inc. | $399.91 | 21 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $364.68 | 27 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,678 | 72 | Phathom Pharmaceuticals, Inc. ($384.48) |
| 2023 | $1,391 | 64 | ABBVIE INC. ($386.69) |
| 2022 | $962.73 | 57 | ABBVIE INC. ($252.45) |
| 2021 | $1,594 | 94 | AbbVie Inc. ($486.55) |
| 2020 | $927.49 | 53 | AbbVie Inc. ($252.59) |
| 2019 | $1,215 | 90 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($237.55) |
| 2018 | $1,302 | 77 | AstraZeneca Pharmaceuticals LP ($319.52) |
| 2017 | $1,448 | 77 | GlaxoSmithKline, LLC. ($269.25) |
All Payment Transactions
584 individual payment records from CMS Open Payments — Page 24 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ZOSTAVAX, JANUMET XR | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/16/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2017 | GlaxoSmithKline, LLC. | ANORO (Drug), INCRUSE | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Central Nervous System (CNS) | ||||||
| 01/30/2017 | Arbor Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | Cash or cash equivalent | $24.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/27/2017 | GlaxoSmithKline, LLC. | ANORO (Drug), BREO, INCRUSE | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: RESPIRATORY | ||||||
| 01/18/2017 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/17/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Diabetes | ||||||
| 01/10/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 65 | 13,358 | 23,011 | $1.4M | $660,592 |
| 2022 | 78 | 13,768 | 22,291 | $1.6M | $690,811 |
| 2021 | 82 | 15,551 | 26,729 | $1.9M | $853,431 |
| 2020 | 65 | 12,044 | 18,844 | $1.3M | $558,689 |
Total Patients
54,721
Total Services
90,875
Medicare Billing
$2.8M
Procedure Codes
290
All Medicare Procedures & Services
290 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 430 | 1,865 | $419,627 | $206,243 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 352 | 878 | $131,767 | $51,180 | 38.8% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 71 | 1,066 | $74,620 | $36,658 | 49.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 246 | 428 | $53,072 | $35,906 | 67.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 183 | 183 | $36,700 | $27,902 | 76.0% |
| 86769 | Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | Office | 2023 | 338 | 481 | $26,455 | $19,860 | 75.1% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 336 | 475 | $35,625 | $19,214 | 53.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 338 | 481 | $33,670 | $13,954 | 41.4% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 337 | 479 | $26,345 | $13,115 | 49.8% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 159 | 163 | $24,983 | $12,806 | 51.3% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 310 | 1,248 | $24,960 | $11,373 | 45.6% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 71 | 328 | $22,960 | $11,279 | 49.1% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 70 | 80 | $28,000 | $11,182 | 39.9% |
| 82627 | Dehydroepiandrosterone (dhea-s) hormone level | Office | 2023 | 338 | 481 | $28,860 | $10,481 | 36.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 341 | 492 | $24,600 | $8,098 | 32.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 367 | 597 | $53,730 | $7,736 | 14.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 167 | 247 | $13,585 | $7,624 | 56.1% |
| 82785 | Ige (immune system protein) level | Office | 2023 | 330 | 472 | $14,160 | $7,613 | 53.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 338 | 482 | $14,460 | $7,124 | 49.3% |
| 86376 | Microsomal antibodies (autoantibody) measurement | Office | 2023 | 341 | 492 | $15,252 | $7,016 | 46.0% |
| 82746 | Folic acid level, serum | Office | 2023 | 337 | 481 | $16,835 | $6,931 | 41.2% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 341 | 492 | $14,760 | $6,839 | 46.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 343 | 500 | $17,500 | $6,560 | 37.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 338 | 482 | $16,870 | $6,440 | 38.2% |
| 86141 | Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | Office | 2023 | 344 | 501 | $12,525 | $6,358 | 50.8% |
About Dr. Stuart Horowitz, DO
Dr. Stuart Horowitz, DO is a Family Medicine healthcare provider based in Massapequa, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972661155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Horowitz, DO has received a total of $10,519 in payments from pharmaceutical and medical device companies, with $1,678 received in 2024. These payments were reported across 584 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($10,513).
As a Medicare-enrolled provider, Horowitz has provided services to 54,721 Medicare beneficiaries, totaling 90,875 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 290 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Massapequa, NY
- Active Since 12/04/2006
- Last Updated 05/16/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972661155
Products in Payments
- XIFAXAN (Drug) $631.05
- QULIPTA (Drug) $482.09
- LINZESS (Drug) $442.78
- VOQUEZNA (Drug) $407.22
- Vascepa (Drug) $399.91
- MAVYRET (Drug) $365.02
- Edarbi (Drug) $358.40
- UBRELVY (Drug) $350.62
- JANUVIA (Drug) $342.79
- TRELEGY ELLIPTA (Drug) $336.08
- Creon (Drug) $301.29
- XARELTO (Drug) $276.56
- FARXIGA (Drug) $273.97
- INJECTAFER (Drug) $269.36
- CREON (Drug) $235.82
- Ozempic (Drug) $233.75
- Edarbyclor (Drug) $228.95
- Horizant (Drug) $228.55
- JARDIANCE (Drug) $195.13
- Livalo (Drug) $194.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Massapequa
Jill Sisselman, D.o, D.O
Family Medicine — Payments: $7,137
Family Medicine $7,137
Dr. Steven Golinowski, D.o, D.O
Family Medicine — Payments: $4,019
Family Medicine $4,019
Dr. Teresa Esposito, Do, DO
Family Medicine — Payments: $3,624
Family Medicine $3,624
Richard Bebirian, Do, DO
Family Medicine — Payments: $2,792
Family Medicine $2,792
Dr. Ching Yeh Lin, M.d, M.D
Family Medicine — Payments: $575.14
Family Medicine $575.14
Dr. John Dimartino, Md, MD
Family Medicine — Payments: $45.02
Family Medicine $45.02